- Home
- DNLI vs CCS Comparison
DNLI vs CCS Comparison
Compare DNLI & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- CCS
- Stock Information
- Founded
- DNLI 2013
- CCS 2000
- Country
- DNLI United States
- CCS United States
- Employees
- DNLI N/A
- CCS N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- CCS Homebuilding
- Sector
- DNLI Health Care
- CCS Consumer Discretionary
- Exchange
- DNLI Nasdaq
- CCS Nasdaq
- Market Cap
- DNLI 3.3B
- CCS 2.7B
- IPO Year
- DNLI 2017
- CCS 2014
- Fundamental
- Price
- DNLI $20.84
- CCS $72.70
- Analyst Decision
- DNLI Strong Buy
- CCS Buy
- Analyst Count
- DNLI 11
- CCS 4
- Target Price
- DNLI $40.40
- CCS $104.00
- AVG Volume (30 Days)
- DNLI 867.7K
- CCS 354.3K
- Earning Date
- DNLI 02-25-2025
- CCS 01-29-2025
- Dividend Yield
- DNLI N/A
- CCS 1.44%
- EPS Growth
- DNLI N/A
- CCS 30.75
- EPS
- DNLI N/A
- CCS 10.03
- Revenue
- DNLI N/A
- CCS $4,330,440,000.00
- Revenue This Year
- DNLI N/A
- CCS $19.66
- Revenue Next Year
- DNLI $420.35
- CCS $14.46
- P/E Ratio
- DNLI N/A
- CCS $7.21
- Revenue Growth
- DNLI 204.74
- CCS 18.13
- 52 Week Low
- DNLI $14.56
- CCS $71.95
- 52 Week High
- DNLI $33.33
- CCS $108.42
- Technical
- Relative Strength Index (RSI)
- DNLI 35.14
- CCS 23.51
- Support Level
- DNLI $19.93
- CCS $71.95
- Resistance Level
- DNLI $21.64
- CCS $76.91
- Average True Range (ATR)
- DNLI 0.96
- CCS 2.23
- MACD
- DNLI -0.06
- CCS -0.49
- Stochastic Oscillator
- DNLI 21.56
- CCS 5.35
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About CCS Century Communities Inc.
Century Communities Inc is a construction company that focuses on the residential market. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its own sales representatives and independent real estate brokers. It also advertises directly to potential homebuyers through the Internet, newspapers, and trade publications. The company generates the majority revenue from the Mountain segment.